ENVB Scorecard | ENVERIC BIOSCIENCES, INC.

ENVERIC BIOSCIENCES, INC. (ENVB) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

20/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseENVB / S&P -28.87% / 15.20%	LoseENVB / S&P ENVB unavailable / 15.00%	LoseENVB / S&P -89.66% / 50.40%
2026-Q10/3	LoseENVB / S&P -46.56% / -4.33%	LoseENVB / S&P ENVB unavailable / 11.30%	LoseENVB / S&P -79.83% / 27.70%
2025-Q40/3	LoseENVB / S&P -52.66% / 2.65%	LoseENVB / S&P ENVB unavailable / 9.00%	LoseENVB / S&P -67.02% / 13.40%
2025-Q30/3	LoseENVB / S&P -47.19% / 8.12%	LoseENVB / S&P ENVB unavailable / 4.61%	LoseENVB / S&P -44.43% / 13.45%
2025-Q20/3	LoseENVB / S&P -12.95% / 10.94%	LoseENVB / S&P ENVB unavailable / 4.83%	LoseENVB / S&P -1.37% / 10.63%
2025-Q10/3	LoseENVB / S&P -98.27% / -4.27%	LoseENVB / S&P ENVB unavailable / 4.98%	LoseENVB / S&P -7.03% / 10.57%
2024-Q40/3	LoseENVB / S&P -24.47% / 2.41%	LoseENVB / S&P ENVB unavailable / 5.25%	LoseENVB / S&P -6.17% / 6.15%
2024-Q31/3	LoseENVB / S&P -24.28% / 5.89%	LoseENVB / S&P ENVB unavailable / 5.89%	WinENVB / S&P 1379.20% / 6.11%
2024-Q21/3	LoseENVB / S&P -37.40% / 4.28%	LoseENVB / S&P ENVB unavailable / 5.38%	WinENVB / S&P 1001.71% / 5.12%
2024-Q11/3	LoseENVB / S&P -23.08% / 10.56%	LoseENVB / S&P ENVB unavailable / 5.71%	WinENVB / S&P 1025.72% / 5.59%
2023-Q40/3	LoseENVB / S&P -45.38% / 11.69%	LoseENVB / S&P ENVB unavailable / 6.81%	LoseENVB / S&P ENVB unavailable / 7.78%
2023-Q30/3	LoseENVB / S&P -29.38% / -3.27%	LoseENVB / S&P ENVB unavailable / 7.52%	LoseENVB / S&P ENVB unavailable / -5.03%
2023-Q21/3	WinENVB / S&P 102.52% / 8.74%	LoseENVB / S&P ENVB unavailable / 9.50%	LoseENVB / S&P ENVB unavailable / -8.57%
2023-Q10/3	LoseENVB / S&P -20.00% / 7.50%	LoseENVB / S&P ENVB unavailable / 10.77%	LoseENVB / S&P ENVB unavailable / -15.69%
2022-Q40/3	LoseENVB / S&P -50.71% / 7.56%	LoseENVB / S&P ENVB unavailable / 11.88%	LoseENVB / S&P ENVB unavailable / -17.99%
2022-Q30/3	LoseENVB / S&P -60.56% / -4.88%	LoseENVB / S&P ENVB unavailable / 13.47%	LoseENVB / S&P ENVB unavailable / -1.41%
2022-Q20/3	LoseENVB / S&P -35.15% / -16.10%	LoseENVB / S&P ENVB unavailable / 13.71%	LoseENVB / S&P ENVB unavailable / 11.04%
2022-Q10/3	LoseENVB / S&P -64.52% / -4.60%	LoseENVB / S&P ENVB unavailable / 15.97%	LoseENVB / S&P ENVB unavailable / 42.23%
2021-Q40/3	LoseENVB / S&P -55.07% / 11.03%	LoseENVB / S&P ENVB unavailable / 15.00%	LoseENVB / S&P ENVB unavailable / 96.40%
2021-Q30/3	LoseENVB / S&P -13.03% / 0.58%	LoseENVB / S&P ENVB unavailable / 10.77%	LoseENVB / S&P ENVB unavailable / 69.42%
2021-Q20/3	LoseENVB / S&P -22.48% / 8.55%	LoseENVB / S&P ENVB unavailable / 6.58%	LoseENVB / S&P ENVB unavailable / 51.81%
2021-Q11/3	WinENVB / S&P 107.43% / 6.17%	LoseENVB / S&P ENVB unavailable / -1.06%	LoseENVB / S&P ENVB unavailable / 7.39%
2020-Q40/3	LoseENVB / S&P -73.19% / 12.15%	LoseENVB / S&P ENVB unavailable / -3.72%	LoseENVB / S&P ENVB unavailable / -33.42%
2020-Q30/3	LoseENVB / S&P -10.97% / 8.93%	LoseENVB / S&P -13.93% / -2.04%	LoseENVB / S&P -89.18% / -27.10%
2020-Q21/3	WinENVB / S&P 61.46% / 20.54%	LoseENVB / S&P -15.25% / -0.46%	LoseENVB / S&P -89.86% / -27.11%
2020-Q10/3	LoseENVB / S&P -57.52% / -19.60%	LoseENVB / S&P -8.89% / 3.47%	LoseENVB / S&P -88.69% / -14.75%
2019-Q40/3	LoseENVB / S&P -46.82% / 9.07%	LoseENVB / S&P -7.17% / 5.36%	LoseENVB / S&P -85.76% / 2.99%
2019-Q31/3	LoseENVB / S&P -51.43% / 1.70%	LoseENVB / S&P -6.87% / 5.02%	WinENVB / S&P 20154.55% / 0.21%
2019-Q22/3	WinENVB / S&P 4.48% / 4.30%	LoseENVB / S&P -7.72% / 6.64%	WinENVB / S&P 3708.62% / 8.65%
2019-Q12/3	WinENVB / S&P 92.53% / 13.65%	LoseENVB / S&P -9.92% / 8.12%	WinENVB / S&P 2690.91% / 14.29%
2018-Q41/3	LoseENVB / S&P -86.62% / -13.52%	LoseENVB / S&P -11.51% / 9.05%	WinENVB / S&P 2634.67% / 18.23%
2018-Q31/3	WinENVB / S&P 26.21% / 7.71%	LoseENVB / S&P -10.82% / 10.21%	LoseENVB / S&P -80.00% / 19.06%
2018-Q21/3	LoseENVB / S&P -37.20% / 3.43%	LoseENVB / S&P -1.98% / 9.03%	WinENVB / S&P 56.76% / 14.46%
2018-Q12/3	LoseENVB / S&P -47.10% / -0.76%	WinENVB / S&P 14.09% / 7.68%	WinENVB / S&P 285.00% / 12.46%
2017-Q42/3	LoseENVB / S&P -52.38% / 6.64%	WinENVB / S&P 34.44% / 7.03%	WinENVB / S&P 275.00% / 13.82%
2017-Q30/3	LoseENVB / S&P -27.67% / 4.48%	LoseENVB / S&P ENVB unavailable / 5.68%	LoseENVB / S&P ENVB unavailable / 17.57%
2017-Q21/3	WinENVB / S&P 38.25% / 3.09%	LoseENVB / S&P ENVB unavailable / 4.83%	LoseENVB / S&P ENVB unavailable / 17.74%
2017-Q10/3	LoseENVB / S&P 0.00% / 6.07%	LoseENVB / S&P ENVB unavailable / 3.67%	LoseENVB / S&P ENVB unavailable / 13.32%
2016-Q40/3	LoseENVB / S&P -7.00% / 3.82%	LoseENVB / S&P ENVB unavailable / 2.09%	LoseENVB / S&P ENVB unavailable / 7.05%
2016-Q31/3	WinENVB / S&P 7.53% / 3.85%	LoseENVB / S&P ENVB unavailable / 0.20%	LoseENVB / S&P ENVB unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	ENVB total return	S&P 500 Total Return Index
Total return	-89.90%	20.78%
Annualized return	-89.90%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	ENVB total return	S&P 500 Total Return Index
Total return	-100.00%	83.14%
Annualized return	-91.35%	12.86%

10Y · 2016-09-01 to 2026-08-27

Metric	ENVB total return	S&P 500 Total Return Index
Total return	-100.00%	319.30%
Annualized return	-83.43%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Pulmatrix, Inc. (PULM)	United States	$0.006B
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54